| pubmed-article:10974231 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10974231 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:10974231 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:10974231 | lifeskim:mentions | umls-concept:C0016011 | lld:lifeskim |
| pubmed-article:10974231 | lifeskim:mentions | umls-concept:C0201925 | lld:lifeskim |
| pubmed-article:10974231 | lifeskim:mentions | umls-concept:C0443199 | lld:lifeskim |
| pubmed-article:10974231 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
| pubmed-article:10974231 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10974231 | pubmed:dateCreated | 2000-10-24 | lld:pubmed |
| pubmed-article:10974231 | pubmed:abstractText | The present study was undertaken to determine the effects of free ionized calcium influenced by either the anticoagulant used (citrate vs. heparin) or directly varying the calcium levels after treatment of blood with citrate on the antiplatelet efficacy of two classes of GPIIb/IIIa antagonists. | lld:pubmed |
| pubmed-article:10974231 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10974231 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10974231 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10974231 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:10974231 | pubmed:issn | 0008-6363 | lld:pubmed |
| pubmed-article:10974231 | pubmed:author | pubmed-author:SleeAA | lld:pubmed |
| pubmed-article:10974231 | pubmed:author | pubmed-author:MousaS ASA | lld:pubmed |
| pubmed-article:10974231 | pubmed:author | pubmed-author:BozarthJ MJM | lld:pubmed |
| pubmed-article:10974231 | pubmed:author | pubmed-author:ForsytheM SMS | lld:pubmed |
| pubmed-article:10974231 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10974231 | pubmed:volume | 47 | lld:pubmed |
| pubmed-article:10974231 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10974231 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10974231 | pubmed:pagination | 819-26 | lld:pubmed |
| pubmed-article:10974231 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:meshHeading | pubmed-meshheading:10974231... | lld:pubmed |
| pubmed-article:10974231 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10974231 | pubmed:articleTitle | Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: role of plasma calcium levels. | lld:pubmed |
| pubmed-article:10974231 | pubmed:affiliation | DuPont Pharmaceuticals Co., Wilmington, DE, USA. shaker.a.mousa@dupontpharma.com | lld:pubmed |
| pubmed-article:10974231 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10974231 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10974231 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10974231 | lld:pubmed |
